Improve Medical Instruments Co., Ltd. (300030.SZ)
CNY 6.6
(-2.37%)
CNY 6.6
(-2.37%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 1.42 Billion CNY | -8.49% |
| 2022 | 1.55 Billion CNY | -14.62% |
| 2021 | 1.82 Billion CNY | 4.6% |
| 2020 | 1.74 Billion CNY | 15.79% |
| 2019 | 1.5 Billion CNY | -0.29% |
| 2018 | 1.51 Billion CNY | -13.44% |
| 2017 | 1.74 Billion CNY | 18.78% |
| 2016 | 1.46 Billion CNY | 2.12% |
| 2015 | 1.43 Billion CNY | 41.2% |
| 2014 | 1.01 Billion CNY | 15.43% |
| 2013 | 883.08 Million CNY | 15.2% |
| 2012 | 766.53 Million CNY | 6.95% |
| 2011 | 716.72 Million CNY | 10.05% |
| 2010 | 651.24 Million CNY | -1.0% |
| 2009 | 657.84 Million CNY | 364.29% |
| 2008 | 141.68 Million CNY | 91.78% |
| 2007 | 73.88 Million CNY | 84.93% |
| 2006 | 39.95 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 1.42 Billion CNY | 0.03% |
| 2024 Q2 | 1.32 Billion CNY | -7.1% |
| 2024 Q3 | 1.33 Billion CNY | 0.42% |
| 2023 Q3 | 1.47 Billion CNY | -2.34% |
| 2023 Q4 | 1.42 Billion CNY | -3.18% |
| 2023 Q2 | 1.5 Billion CNY | -4.29% |
| 2023 Q1 | 1.57 Billion CNY | 1.12% |
| 2023 FY | 1.42 Billion CNY | -8.49% |
| 2022 Q1 | 1.78 Billion CNY | -1.99% |
| 2022 Q3 | 1.66 Billion CNY | -0.36% |
| 2022 Q4 | 1.55 Billion CNY | -6.33% |
| 2022 FY | 1.55 Billion CNY | -14.62% |
| 2022 Q2 | 1.66 Billion CNY | -6.67% |
| 2021 Q2 | 1.8 Billion CNY | -2.47% |
| 2021 Q3 | 1.75 Billion CNY | -3.07% |
| 2021 FY | 1.82 Billion CNY | 4.6% |
| 2021 Q1 | 1.85 Billion CNY | 6.32% |
| 2021 Q4 | 1.82 Billion CNY | 4.07% |
| 2020 Q2 | 1.6 Billion CNY | 4.93% |
| 2020 Q4 | 1.74 Billion CNY | 1.39% |
| 2020 Q3 | 1.72 Billion CNY | 7.45% |
| 2020 FY | 1.74 Billion CNY | 15.79% |
| 2020 Q1 | 1.52 Billion CNY | 1.29% |
| 2019 Q4 | 1.5 Billion CNY | -1.54% |
| 2019 FY | 1.5 Billion CNY | -0.29% |
| 2019 Q1 | 1.46 Billion CNY | -3.14% |
| 2019 Q2 | 1.51 Billion CNY | 3.75% |
| 2019 Q3 | 1.53 Billion CNY | 0.77% |
| 2018 FY | 1.51 Billion CNY | -13.44% |
| 2018 Q4 | 1.51 Billion CNY | -10.45% |
| 2018 Q3 | 1.68 Billion CNY | 0.09% |
| 2018 Q2 | 1.68 Billion CNY | 0.5% |
| 2018 Q1 | 1.67 Billion CNY | -3.91% |
| 2017 Q1 | 1.57 Billion CNY | 7.18% |
| 2017 FY | 1.74 Billion CNY | 18.78% |
| 2017 Q4 | 1.74 Billion CNY | -0.84% |
| 2017 Q3 | 1.76 Billion CNY | -1.16% |
| 2017 Q2 | 1.78 Billion CNY | 13.07% |
| 2016 Q3 | 1.44 Billion CNY | 2.43% |
| 2016 Q2 | 1.41 Billion CNY | 3.69% |
| 2016 Q1 | 1.36 Billion CNY | -5.45% |
| 2016 FY | 1.46 Billion CNY | 2.12% |
| 2016 Q4 | 1.46 Billion CNY | 1.69% |
| 2015 Q4 | 1.43 Billion CNY | 8.18% |
| 2015 Q1 | 1.08 Billion CNY | 6.03% |
| 2015 FY | 1.43 Billion CNY | 41.2% |
| 2015 Q3 | 1.33 Billion CNY | 18.75% |
| 2015 Q2 | 1.12 Billion CNY | 3.67% |
| 2014 FY | 1.01 Billion CNY | 15.43% |
| 2014 Q4 | 1.01 Billion CNY | 5.66% |
| 2014 Q3 | 964.77 Million CNY | 3.51% |
| 2014 Q2 | 932.02 Million CNY | 6.57% |
| 2014 Q1 | 874.58 Million CNY | -0.96% |
| 2013 Q4 | 883.08 Million CNY | 3.32% |
| 2013 FY | 883.08 Million CNY | 15.2% |
| 2013 Q1 | 802.02 Million CNY | 4.63% |
| 2013 Q2 | 809.38 Million CNY | 0.92% |
| 2013 Q3 | 854.71 Million CNY | 5.6% |
| 2012 Q1 | 715.02 Million CNY | -0.24% |
| 2012 Q2 | 722.5 Million CNY | 1.05% |
| 2012 Q4 | 766.53 Million CNY | 1.92% |
| 2012 FY | 766.53 Million CNY | 6.95% |
| 2012 Q3 | 752.07 Million CNY | 4.09% |
| 2011 Q2 | 684.93 Million CNY | 1.88% |
| 2011 FY | 716.72 Million CNY | 10.05% |
| 2011 Q4 | 716.72 Million CNY | 2.7% |
| 2011 Q1 | 672.28 Million CNY | 3.23% |
| 2011 Q3 | 697.86 Million CNY | 1.89% |
| 2010 Q3 | 650.12 Million CNY | 3.67% |
| 2010 Q2 | 627.12 Million CNY | 0.98% |
| 2010 Q1 | 621.05 Million CNY | -5.59% |
| 2010 FY | 651.24 Million CNY | -1.0% |
| 2010 Q4 | 651.24 Million CNY | 0.17% |
| 2009 Q2 | 189.29 Million CNY | 0.0% |
| 2009 Q3 | 201.43 Million CNY | 6.41% |
| 2009 Q4 | 657.84 Million CNY | 226.58% |
| 2009 FY | 657.84 Million CNY | 364.29% |
| 2008 Q4 | 141.68 Million CNY | 0.0% |
| 2008 FY | 141.68 Million CNY | 91.78% |
| 2007 FY | 73.88 Million CNY | 84.93% |
| 2006 FY | 39.95 Million CNY | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. | 15.96 Billion CNY | 91.07% |
| Shenzhen Salubris Pharmaceuticals Co., Ltd. | 9.39 Billion CNY | 84.825% |
| Blue Sail Medical Co.,Ltd. | 15.63 Billion CNY | 90.879% |
| Andon Health Co., Ltd. | 22.61 Billion CNY | 93.696% |
| Allmed Medical Products Co., Ltd | 5.08 Billion CNY | 71.954% |
| Tofflon Science and Technology Group Co., Ltd. | 12.89 Billion CNY | 88.945% |
| Truking Technology Limited | 11.66 Billion CNY | 87.773% |
| Jiangxi Sanxin Medtec Co.,Ltd. | 2.03 Billion CNY | 29.784% |
| Shenyang Xingqi Pharmaceutical Co.,Ltd | 2.02 Billion CNY | 29.542% |
| Autek China Inc. | 5.51 Billion CNY | 74.162% |
| Intco Medical Technology Co., Ltd. | 27.07 Billion CNY | 94.734% |
| Jiangsu Apon Medical Technology Co., Ltd. | 859.57 Million CNY | -65.891% |
| Winner Medical Co., Ltd. | 17.11 Billion CNY | 91.667% |
| Imeik Technology Development Co.,Ltd. | 6.85 Billion CNY | 79.19% |
| Zhonghong Pulin Medical Products Co., Ltd. | 7.05 Billion CNY | 79.794% |
| Caina Technology Co., Ltd. | 1.92 Billion CNY | 26.082% |